fbpx

Suave 24-Hour Protection Powder Aerosol Antiperspirant Benzene Class Action

Suave 24-Hour Protection Powder Aerosol Antiperspirant is a product of Unilever United States, Inc. This class action alleges that this product is “defective,” because it contains benzene, “a known carcinogen that offers no therapeutic deodorant or antiperspirant benefit.”

The National Class for this action is all persons in the US who bought the product between November 19, 2018 and the date of judgment in this case. An Illinois Subclass has also been defined for persons in Illinois who bought the product.

Unilever is known for its personal care products. Its website claims, “The safety of our products is our top priority. That is why each new product is evaluated systematically and scientifically by our team in the Safety and Environmental Assurance Centre (SEAC). Our scientists consider any safety risks to the consumers who use our products, to the workers who make them, and to the environment to ensure all our products are safe to use.”

“In reality,” the complaint alleges, “the [Suave] Product contains significant concentrations of benzene, a harmful carcinogen.”

The Food and Drug Administration (FDA) classifies deodorants as cosmetics and antiperspirants as drugs, and regulates them accordingly.

The FDA has not decreed any “safe” level of benzene and issues guidance that this chemical “should not be employed in the manufacture of drug substances, excipients, and drug products because of [its] unacceptable toxicity.” However, the guidance says, “if [benzene’s] use is unavoidable in order to produce a drug product with a significant therapeutic advance, then [its] levels should be restricted” to two parts per million (ppm).

The complaint alleges that the use of benzene in the Suave antiperspirant “is demonstrably avoidable” because other makers of the same kind of product did avoid it. Even if it were “unavoidable,” the complaint points out that the concentration of benzene in the product is not 2 ppm but 5.21 ppm—more than double the FDA’s concentration limit.

How was the benzene found? The complaint alleges that Valisure, “an analytical pharmacy and consumer protection organization,” conducted tests that found benzene in a number of deodorants and antiperspirants. It then petitioned the FDA to address the problem.

A number of health organizations have classified benzene as a carcinogen. The complaint alleges, “Long-term exposure to benzene additionally causes harmful effects on the bone marrow and can cause a decrease in red blood cells, leading to anemia. It can also cause excessive bleeding and can affect the immune system, increasing the chance for infection.”

The complaint alleges that the Suave product is adulterated and illegal to sell because of the significant concentration of benzene.

The counts include breaches of warranties, among other things.

Article Type: Lawsuit
Topic: Consumer

Most Recent Case Event

Suave 24-Hour Protection Powder Aerosol Antiperspirant Benzene Complaint

November 19, 2021

Suave 24-Hour Protection Powder Aerosol Antiperspirant is a product of Unilever United States, Inc. This class action alleges that this product is “defective,” because it contains benzene, “a known carcinogen that offers no therapeutic deodorant or antiperspirant benefit.”

Suave 24-Hour Protection Powder Aerosol Antiperspirant Benzene Complaint

Case Event History

Suave 24-Hour Protection Powder Aerosol Antiperspirant Benzene Complaint

November 19, 2021

Suave 24-Hour Protection Powder Aerosol Antiperspirant is a product of Unilever United States, Inc. This class action alleges that this product is “defective,” because it contains benzene, “a known carcinogen that offers no therapeutic deodorant or antiperspirant benefit.”

Suave 24-Hour Protection Powder Aerosol Antiperspirant Benzene Complaint
Tags: Contaminated with Harmful Substances, Deceptive Advertising